stockrowInteger Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
Follow ITGR
Alert me
Integer Holdings Corporation (ITGR) Revenue growth
Integer Holdings Corporation's revenue growth over the twelve months to 30 September 2026 was −0.31%, down 8.3 percentage points from fiscal 2025 (7.98%). Over the past ten years it has ranged from −14.7% (fiscal 2020) to 34.4% (fiscal 2016); the current reading is higher than 45% of that period. That is below the Medical Devices industry median of 10.4% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 7.98% | (2.37) |
| FY2024 | 10.4% | (6.50) |
| FY2023 | 16.9% | 7.83 |
| FY2022 | 9.02% | (4.73) |
| FY2021 | 13.8% | 28.43 |
| FY2020 | −14.7% | (18.23) |
| FY2019 | 3.55% | (3.40) |
| FY2018 | 6.95% | 1.32 |
| FY2017 | 5.63% | (28.74) |
| FY2016 | 34.4% | 17.99 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | −3.86% | (1.26) |
| Jun 2026 | −2.60% | (3.10) |
| Mar 2026 | 0.50% | (4.52) |
| Dec 2025 | 5.02% | (3.39) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| TMDX TransMedics Group, Inc. compare | 28.5% |
| AXGN AxoGen, Inc. compare | 24.3% |
| IRTC iRhythm Holdings, Inc. compare | 21.6% |
| LIVN LivaNova PLC compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 8.62% |
| HAE Haemonetics Corporation compare | 4.11% |
| ITGR Integer Holdings Corporation | −0.31% |
| NEOG Neogen Corporation compare | −0.33% |
| TXG 10x Genomics compare | −4.28% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ITGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement